cdmo.directory
← Compare landing

Biomay AG vs ElevateBio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/biomay/elevate

CategoryBiomay AGElevateBio
Listed sitecdmocdmo
SummaryGMP CDMO specializing in plasmid DNA, mRNA, and recombinant protein manufacturing from gene construction to market supply, with in-house mRNA lipid-nanoparticle formulation and aseptic fill-finish capabilities.Advanced therapies CDMO providing discovery, process development, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA, and gene editing programs from preclinical through commercial scale.
Services
  • mRNA Manufacturing
  • Cell-Line Development
  • Recombinant Protein Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
  • Cell-Line Development
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • mRNA Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Vaccine Manufacturing
Modalities
  • mRNA
  • Gene Therapy
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
IndicationsData not yet provided.
  • Rare Disease
  • Oncology
Locations
  • Headquarters, Vienna, Austria
  • Corporate Headquarters and BaseCamp Waltham, Waltham, MA, USA
  • BaseCamp Pittsburgh, Pittsburgh, PA, USA
  • Gene Editing and Research & Development Site, Durham, NC, USA
  • Process Development Labs and Corporate Offices, Waltham, MA, USA
Certifications
  • EMA · Identifier: GMP
  • ICMC · Identifier: ICMC™ Certified for Clinical and Commercial Cell and Gene Therapy Manufacturing Capabilities
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.